Carnitine Palmityl Transferase Deficiency
  • Clinical Trials
  • Definition - one of a group of muscle diseases that interfere with the processing of fats for energy production

    Cause - a genetic defect in the carnitine palmityl transferase 2 (CPT2) enzyme, which
    normally escorts breakdown products of fats from the main part of the muscle cell into the mitochondria, where they can be further metabolized for energy

    Onset - infancy to adulthood

    Symptoms - episodic muscle pain, stiffness and tenderness; myoglobinuria (rust-colored urine indicating breakdown of muscle tissue) can occur; usually brought on by prolonged intense exercise, but illness, cold, stress, menstruation can also provoke symptoms

    Progression - if enzyme completely lost, rapid progression leading to death in infancy; if some enzyme activity remains, little or no progression with normal strength between episodes

    Inheritance - generally autosomal recessive, meaning caused by the contribution of a defective gene from each parent; some genetic defects cause symptoms even if the gene from only one parent contains the flaw (mutation)

    Facts About Metabolic Diseases of Muscle